Scholars Central

Review articlePublished 30 Jul 2021

Remdesivir Effectiveness against COVID-19

Authors: Sumit Tiwari, Shivang Sharma

General Medicine: Open Access

Volume 9 · Issue 7 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This paper determines the study of dosing and treatment therapy and drug effectiveness used for hospitalized COVID-19 patients whom are being administered Remdesivir in a large, multi-center, clinical trial led by NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Remdesivir has been as of late a solid contender for the treatment of COVID-19 and in this critique, some of scientist depicted the structure of the coronavirus in a straightforward manner just as the site where Remdesivir acts whereas in continuous clinical preliminaries, just as a distributed report that was led on merciful base and The COVID-19 pandemic may wean somewhere near the finish of summer 2020, yet the danger of regularity exists. Hence, future removal of operators, for example, Remdesivir may be critical for guaranteeing a proficient treatment, decline mortality and permit early release.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in General Medicine: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGeneral Medicine: Open Access
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Sumit Tiwari”
  • BylineArticles whose byline prints “Shivang Sharma”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels